5.365
price up icon7.30%   0.365
after-market アフターアワーズ: 5.02 -0.345 -6.43%
loading
前日終値:
$5.00
開ける:
$5.12
24時間の取引高:
2.17M
Relative Volume:
0.81
時価総額:
$799.68M
収益:
-
当期純損益:
$-207.02M
株価収益率:
-3.8106
EPS:
-1.4079
ネットキャッシュフロー:
$-176.59M
1週間 パフォーマンス:
-1.01%
1か月 パフォーマンス:
+5.40%
6か月 パフォーマンス:
+92.29%
1年 パフォーマンス:
+117.21%
1日の値動き範囲:
Value
$5.09
$5.52
1週間の範囲:
Value
$4.95
$5.62
52週間の値動き範囲:
Value
$1.285
$7.18

Annexon Inc Stock (ANNX) Company Profile

Name
名前
Annexon Inc
Name
セクター
Healthcare (1114)
Name
電話
(650) 822-5500
Name
住所
1400 SIERRA POINT PARKWAY, BRISBANE
Name
職員
99
Name
Twitter
Name
次回の収益日
2026-03-30
Name
最新のSEC提出書
Name
ANNX's Discussions on Twitter

Compare ANNX vs VRTX, REGN, ALNY, ARGX, INSM

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ANNX icon
ANNX
Annexon Inc
5.365 745.28M 0 -207.02M -176.59M -1.4079
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
454.97 113.96B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
749.47 78.41B 14.34B 4.50B 3.77B 41.56
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
328.70 40.85B 3.71B 313.75M 465.38M 2.2571
ARGX icon
ARGX
Argen X Se Adr
697.05 42.05B 4.16B 1.29B 734.26M 19.58
INSM icon
INSM
Insmed Inc
148.31 29.99B 606.42M -1.28B -997.58M -6.403

Annexon Inc Stock (ANNX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-23 開始されました Chardan Capital Markets Buy
2024-03-01 アップグレード JP Morgan Neutral → Overweight
2023-12-21 アップグレード BofA Securities Neutral → Buy
2023-10-30 開始されました Wells Fargo Overweight
2023-05-26 ダウングレード BofA Securities Buy → Neutral
2023-05-25 ダウングレード JP Morgan Overweight → Neutral
2022-09-16 開始されました Jefferies Buy
2022-09-09 開始されました BTIG Research Buy
2021-11-30 開始されました H.C. Wainwright Buy
2021-09-23 開始されました Cantor Fitzgerald Overweight
2021-01-26 開始されました Needham Buy
2020-08-18 開始されました BofA Securities Buy
2020-08-18 開始されました Cowen Outperform
2020-08-18 開始されました JP Morgan Overweight
すべてを表示

Annexon Inc (ANNX) 最新ニュース

pulisher
Mar 25, 2026

Annexon (NASDAQ:ANNX) Trading Up 10.2%What's Next? - MarketBeat

Mar 25, 2026
pulisher
Mar 23, 2026

Are Healthcare Stocks Falling Behind American Well (AMWL) in Performance This Year? - Bitget

Mar 23, 2026
pulisher
Mar 23, 2026

Are Medical Stocks Lagging American Well (AMWL) This Year? - Yahoo Finance

Mar 23, 2026
pulisher
Mar 22, 2026

If You Invested $1,000 in Annexon, Inc. (ANNX) - Stock Titan

Mar 22, 2026
pulisher
Mar 20, 2026

ANNX PE Ratio & Valuation, Is ANNX Overvalued - Intellectia AI

Mar 20, 2026
pulisher
Mar 20, 2026

Annexon, Inc. (ANNX) Discusses Vision Preservation in Geographic Atrophy With C1q Inhibition and Key Insights From ARCHER TrialsSlideshow (NASDAQ:ANNX) 2026-03-20 - Seeking Alpha

Mar 20, 2026
pulisher
Mar 20, 2026

Chardan Capital Maintains Buy Rating on Annexon (ANNX) with $16 - GuruFocus

Mar 20, 2026
pulisher
Mar 20, 2026

Annexon's (ANNX) "Buy" Rating Reaffirmed at Chardan Capital - MarketBeat

Mar 20, 2026
pulisher
Mar 20, 2026

H.C. Wainwright reiterates Buy on Annexon stock, $14 target By Investing.com - Investing.com Canada

Mar 20, 2026
pulisher
Mar 19, 2026

Annexon Inc to Host KOL Event Transcript - GuruFocus

Mar 19, 2026
pulisher
Mar 19, 2026

ANNX Earnings History & Surprises | EPS & Revenue Results | ANNEXON INC (NASDAQ:ANNX) - ChartMill

Mar 19, 2026
pulisher
Mar 18, 2026

Annexon Investor Day: ANX007 Targets C1q in Dry AMD GA as Phase III Readout Nears Q4 - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

ANNX: Phase III trial for C1q inhibition in GA is fully enrolled, with results expected in Q4 - TradingView

Mar 18, 2026
pulisher
Mar 18, 2026

ANNX: Phase III trial for C1q inhibition in GA targets vision preservation with robust clinical design - TradingView

Mar 18, 2026
pulisher
Mar 17, 2026

Portfolio Update: Will Annexon Inc benefit from government policyWeekly Stock Summary & AI Enhanced Trade Execution Alerts - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 16, 2026

Annexon reports inducement grant to new employee under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

Mar 16, 2026
pulisher
Mar 16, 2026

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 16, 2026
pulisher
Mar 13, 2026

ANNX SEC FilingsAnnexon, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 13, 2026
pulisher
Mar 13, 2026

Wall Street Recap: Is Annexon Inc in a bullish channel2026 Macro Moves & Technical Confirmation Alerts - baoquankhu1.vn

Mar 13, 2026
pulisher
Mar 12, 2026

Insider Buying: William Carson Acquires 8,000 Shares of Annexon Inc (ANNX) - GuruFocus

Mar 12, 2026
pulisher
Mar 12, 2026

William Carson Acquires 8,000 Shares of Annexon (NASDAQ:ANNX) Stock - MarketBeat

Mar 12, 2026
pulisher
Mar 12, 2026

[Form 4] Annexon, Inc. Insider Trading Activity - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

Annexon (NASDAQ:ANNX) Stock Price Down 8.1%Should You Sell? - MarketBeat

Mar 12, 2026
pulisher
Mar 09, 2026

Annexon (NASDAQ:ANNX) Shares Up 6.8%Time to Buy? - MarketBeat

Mar 09, 2026
pulisher
Mar 08, 2026

Rhenman & Partners Asset Management AB Boosts Holdings in Annexon, Inc. $ANNX - MarketBeat

Mar 08, 2026
pulisher
Mar 04, 2026

Annexon (ANNX) CFO Lew sells shares to cover RSU tax withholding - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Annexon, Inc. (ANNX) CMO sells shares to cover tax obligations - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Annexon (ANNX) EVP Overdorf sells shares to cover RSU tax - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Annexon (ANNX) EVP sells 5,566 shares to cover RSU tax withholding - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Annexon Spotlights GA Phase III, GBS Regulatory Plans and ANX1502 Update at TD Cowen Conference - MarketBeat

Mar 04, 2026
pulisher
Mar 03, 2026

ANNX: Late-stage neuroinflammatory programs near key data and filings, with strong commercial focus - TradingView

Mar 03, 2026
pulisher
Mar 02, 2026

Director files sale notice for 5,566 ANNX shares (NASDAQ: ANNX) - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

ANNX (NASDAQ: ANNX) Rule 144 notice shows 5,894 shares to be sold; prior 5,290 sold - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

ANNX (NASDAQ) Rule 144: Insider sale of 6,225 shares; 4,339 vested - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

ANNX (NASDAQ: ANNX) Form 144 lists 5,565-share notice and recent insider sale - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 02, 2026
pulisher
Mar 01, 2026

ANNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 01, 2026
pulisher
Feb 28, 2026

Annexon Showcases Promising Drug Ahead of Pivotal Trial Data - StocksToTrade

Feb 28, 2026
pulisher
Feb 28, 2026

Annexon Showcases Emerging Treatment with Topline Data on Horizon - timothysykes.com

Feb 28, 2026
pulisher
Feb 27, 2026

ANNX Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 27, 2026
pulisher
Feb 27, 2026

Annexon Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView

Feb 27, 2026
pulisher
Feb 27, 2026

Does Annexon Inc. meet Warren Buffett’s criteriaEarnings Performance Report & Weekly Watchlist for Consistent Profits - mfd.ru

Feb 27, 2026
pulisher
Feb 27, 2026

ANNX (NASDAQ: ANNX) insider sale notice: 5,820 shares tied to vesting - Stock Titan

Feb 27, 2026
pulisher
Feb 24, 2026

Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference - Investing News Network

Feb 24, 2026
pulisher
Feb 23, 2026

Annexon (ANNX) CFO receives 250,000 options and 62,500 RSUs in equity grant - Stock Titan

Feb 23, 2026
pulisher
Feb 23, 2026

Annexon (ANNX) grants CMO 225,000 options and 56,250 RSUs - Stock Titan

Feb 23, 2026
pulisher
Feb 20, 2026

Jamie Dananberg Sells 5,290 Shares of Annexon (NASDAQ:ANNX) Stock - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Insider Selling: Annexon (NASDAQ:ANNX) EVP Sells 5,290 Shares of Stock - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Annexon (NASDAQ:ANNX) EVP Sells $40,149.27 in Stock - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Annexon (NASDAQ:ANNX) CFO Sells $40,118.61 in Stock - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Annexon (ANNX) EVP sells 7,857 shares to cover RSU tax withholding - Stock Titan

Feb 20, 2026

Annexon Inc (ANNX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$27.36
price up icon 1.82%
$47.03
price up icon 3.20%
$53.54
price up icon 4.29%
$88.77
price up icon 2.26%
ONC ONC
$283.45
price up icon 2.81%
$148.31
price up icon 6.59%
大文字化:     |  ボリューム (24 時間):